We are committed to provide our readers with leading information on all aspects of MS, NMO and related autoimmune diseases of the central nervous system.

London, United Kingdom
Our journals are part of the international community of @ECTRIMS @ACTRIMS @PACTRIMS_admin @lactrims_org and @eurims You can read our articles on: Multiple Sclerosis Journal journals.sagepub.com/home/ms… MSJ Experimental Translational and Clinical journals.sagepub.com/home/ms…
1
1
15
#MultipleSclerosis therapies in women are associated with increased risks of HPV positivity, cervical dysplasia/cancer, cervicitis, herpes simplex virus, vulvovaginitis, and Bartholin cysts/abscess. Study from @harvardmed @UCSF ▶️ journals.sagepub.com/doi/10.…
5
22
850
📢September issue is now available 🔽 journals.sagepub.com/toc/MSJ… ...and the cover goes to @UBC @UCSF and North American Imaging in Multiple Sclerosis #NAIMS Cooperative with their review on spinal cord imaging for #MultipleSclerosis ▶️journals.sagepub.com/doi/10.…
3
15
579
A 35-year-old woman with relapsing #MultipleSclerosis continued ofatumumab until 28 weeks of gestation and resumed maintenance therapy postpartum without re-induction. Her infant showed normal B cells and completed vaccinations. 🔓 MSJ-ETC case report ▶️ journals.sagepub.com/doi/10.…
4
14
728
Close call!
Replying to @MSJ_Research
What do you think? Resources aside, would you like your family to be screened for #MultipleSclerosis? 5/🧵
2
520
A 31-year-old male with #MultipleSclerosis on ofatumumab who had a bat fly into his hand, needed the standard rabies vaccination series and two additional booster vaccinations, to establish humoral. 🔓MSJ-ETC case report from @UTSWMedCenter ▶️ journals.sagepub.com/doi/10.…
5
10
533
Juxtacortical paramagnetic rims are a characteristic feature of cortical lesions with greater clinical and radiological burden in #MultipleSclerosis. Study from @CQMU1956 @QSMSCENTRE @UCLIoN @UCLBrainScience ▶️ journals.sagepub.com/doi/10.…
7
12
877
MSJ retweeted
🎥 Why are fellowships at the heart of ECTRIMS activities? In this short video, Prof. Gabriel Bsteh from the Medizinische Universität Wien highlights how @ECTRIMS Fellowships empower young researchers and clinicians to access opportunities they might not have at home — from advanced education to cutting-edge scientific and clinical training. Fellowships are more than just time abroad. They create lasting bonds: most fellows remain active contributors to the ECTRIMS community long after their fellowship ends. 📅 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 1 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 2026 ▶️ 𝐀𝐩𝐩𝐥𝐲 𝐯𝐢𝐚 𝐦𝐲𝐄𝐂𝐓𝐑𝐈𝐌𝐒: bit.ly/3ZBesDZ #MSResearch #Fellowships #ECTRIMSNextGen
2
6
380
In >10 years, 17.2% people with relapsing-onset #MultipleSclerosis transitioned to secondary progression, of whom 92.8% were not relapsing by the final visit. 🔓MSJ-ETC study from @Gauruv @MassGenBrigham @harvardmed @OttawaHospital @uOttawaMed ▶️ journals.sagepub.com/doi/10.…
1
4
15
973
New controversy available ⚖️ Resources aside, would you like your family to be screened for #MultipleSclerosis? 1/🧵
1
2
6
412
And commentary from @DalhousieU @UTAS_: We must fully understand what factors (age, family history, perceived severity or treatability) would influence decision-making, and demonstrate secondary prevention of #MultipleSclerosis. 🔽 journals.sagepub.com/doi/ful… 4/🧵
1
88
What do you think? Resources aside, would you like your family to be screened for #MultipleSclerosis? 5/🧵
50% Yes
50% No
0% So scary
4 votes • Final results
1
417
In this #MultipleSclerosis population predominantly aged 50 years or older, the recombinant zoster vaccine demonstrated robust effectiveness, preventing 64%–81% of herpes zoster cases. Study from @harvardmed @HarvardPilgrim @PennNeurology ▶️ journals.sagepub.com/doi/10.…
2
9
505
🔊 Listen to @MSIntFederation on the global prevalence of multiple sclerosis surpassing 3 million in 2024. 📄 And read the full manuscript ▶️ journals.sagepub.com/doi/10.…
2
226
Increased variability in physical exertion affects subjective effort assessment in individuals with #MultipleSclerosis, reflecting why exertion feels particularly costly. Study from @JohnsHopkins ▶️ journals.sagepub.com/doi/ful…
1
4
251
In multiple sclerosis, starting kesimpta shortly after stopping tysabri is effective in preventing post-tysabri rebound disease activity according to this case series of 61 people with MS (mean follow up 2.4 years; no relapses or MRI activity) journals.sagepub.com/doi/10.…
3
7
42
2,306
Early cognitive impairment is prevalent in 47% of children with #MultipleSclerosis and 43% with #MOGAD, with difficulties in complex attention. Study from @ErasmusMC ▶️ journals.sagepub.com/doi/ful…
5
12
550
Let's do it!
Replying to @MSJ_Research
What do you think? #MultipleSclerosis phenotypes should be abandoned in favour of a continuous disease spectrum model? 5/🧵
4
549